MEDIAN TECHNOLOGIES Aktie [WKN DE: A1JCLB / ISIN: FR0011049824]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu MEDIAN TECHNOLOGIES

26.11.24		Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis™ LCS at the Radiological Society of North America (RSNA) 2024 (Businesswire)
07.11.24		Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis™ Lung Cancer Screening (LCS) REALITY Data (Businesswire)
30.10.24		Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening (Businesswire)
24.10.24		Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results (Businesswire)
11.09.24		Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024 (Businesswire)
04.09.24		Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer (Businesswire)
02.09.24		Median Technologies to host two webcasts on September 5, 2024 (Businesswire)
29.08.24		Median Technologies Announces Pivotal REALITY Study of Its eyonis™ LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints (Businesswire)
06.08.24		Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery (Businesswire)
07.06.24		Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024 (Businesswire)
03.06.24		Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 19, 2024 (Businesswire)
29.05.24		Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA (Businesswire)
21.05.24		Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company (Businesswire)
25.04.24		Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information (Businesswire)
29.02.24		Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference (Businesswire)
26.02.24		Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria (Businesswire)
29.01.24		Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook (Businesswire)
26.01.24		New Date for Median Technologies’ Webcasts: February 1st, 2024 (Businesswire)
25.01.24		Median Technologies to Host Two Webcasts, and Provide a Company Update on January 30, 2024 (Businesswire)
27.12.23		Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan (Businesswire)
14.12.23		Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine (Businesswire)
30.11.23		Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with two Presentations (Businesswire)
27.11.23		Median Technologies Selected for Support Under the French Government's ETIncelles Program (Businesswire)
26.11.23		Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™ (Businesswire)
22.11.23		Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 - 30, Chicago, IL, USA (Businesswire)
19.10.23		Median Technologies Reports 2023 Half-year Results and Business Indicators for the Third Quarter of 2023 (Businesswire)
17.10.23		First Results of Median Technologies’ iBiopsy® HCC Detection AI Model Developed on the PHELICAR Clinical Data Registry, to Be Presented at the ESMO Congress (Oct 20-24, 2023, Madrid, Spain) (Businesswire)
16.10.23		Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain (Businesswire)
10.10.23		Median Technologies Appoints Ben McDonald to its Board of Directors (Businesswire)
26.07.23		Median Technologies: Financial Communication Schedule for the Second Half of 2023 (Businesswire)
21.07.23		Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a "Strong Buy” Recommendation (Businesswire)
17.07.23		Median Technologies to Host Two Webcasts and Provide a Company Update on July 20, 2023 (Businesswire)
17.07.23		Median Technologies Announces Onboarding of All Academic Sites Involved in the Pivotal Validation Plan for iBiopsy® LCS CADe/CADx SaMD (Businesswire)
12.07.23		Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan (Businesswire)
30.05.23		Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 20, 2023 (Businesswire)
25.04.23		Median Technologies Reschedules Its Corporate Update Webcasts on May 4, 2023 (Businesswire)
24.04.23		Median Technologies to Host Two Webcasts and Provide a Company Update on May 3, 2023 (Businesswire)
20.04.23		Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023 (Businesswire)
27.02.23		Median Technologies Announces Completion of the Q-Submission Phase with the FDA for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device (Businesswire)
23.02.23		Median Technologies to Participate in the Cowen’s 43rd Annual Health Care Conference (Businesswire)
24.01.23		Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023 (Businesswire)
19.01.23		Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million (Businesswire)
21.12.22		Median Technologies: Financial Communications Schedule for the First Half of 2023 (Businesswire)
22.11.22		Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations (Businesswire)
20.10.22		Median Technologies Announces Its 2022 Half-year Results and Revenues for the Third Quarter (Businesswire)
03.10.22		Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening (Businesswire)
06.09.22		Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy® (Businesswire)
25.07.22		Median Technologies: Financial Communication Schedule for the Second Half of 2022 (Businesswire)
11.07.22		Median Technologies Communicates Its Business Indicators for the Second Quarter of 2022 (Businesswire)
08.07.22		Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy® (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Pierer-Aktie letztlich zweistellig höher: KTM ist insolvent - Antrag auf Sanierung in Eigenverwaltung

Solana Kurs Prognose: 300 US-Dollar noch in diesem Jahr?

Pierer Mobility-Aktie unter Druck: KTM-Pleite - Schockstarre in der Region und bei den Zulieferern - Land OÖ signalisiert Bereitschaft Beschäftigten zu helfen

voestalpine-Aktie zieht an: Erste Group stuft Aktie von "Accumulate" auf "Buy" hoch

Rosenbauer erwartet kein Problem bei Kapitalerhöhung wegen KTM-Pleite - Rosenbauer-Aktie fester

Pierer Mobility-Aktie bricht ein: KTM steht vor Insolvenz

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	30.11.2024 22:30
Kaufwert:	EUR
	Hinzufügen Speichern